Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization. A Randomized Controlled Trial

NCT07242534 is registered in ClinicalTrials.gov with Fundacion Dexeus as lead sponsor.

NCT NCT07242534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07242534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization. A Randomized Controlled Trial
Lead sponsor
Fundacion Dexeus
Phase
Phase 4
Overall status
Recruiting
Start date
January 19, 2026
Completion date
May 31, 2027
Enrollment
62 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, obesity